Skip to content

Green Tea and Alzheimer’s Disease Therapy

February 5, 2012

Lopez Del Amo et al, studied the green tea compound epigallocatechin-3-gallate (EGCG).  They demonstrated that it can inhibit Alzheimer’s disease β-amyloid peptide (Aβ) neurotoxicity.

They demonstrated that EGCG-induced Aβ oligomers to adopt a well-defined structure and interferes with the aromatic hydrophobic core of Aβ.

The structural analysis of small-molecule-induced amyloid aggregates potentiates drug development for Alzheimer’s disease therapies.

Have a cuppa!


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: